regulatory status is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-26. Numbers and descriptions here follow the published literature rather than marketing material.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
== Pathophysiology == Copper functions as a prosthetic group, permitting electron transfers in key enzymatic pathways like the electron transport chain. Copper is integrated in the enzymes cytochrome c oxidase, which is involved in cellular respiration and oxidative phosphorylation, Cu/Zn dismutase, which is involved in antioxidant defense, and many more listed in the table below.
The Yemeni crisis began with the 2011–2012 revolution against President Abdullah Saleh, who had led Yemen for 33 years. After Saleh left office in early 2012 as part of a mediated agreement between the Yemeni government and opposition groups, the government led by Saleh's former vice president, Abdrabbuh Mansur Hadi, faced challenges in governing Yemen’s divided political landscape and addressing armed opposition from Al-Qaeda in the Arabian Peninsula and the Houthi militant movement that had been waging a protracted insurgency in the north for years. In September 2014, the conflict escalated into a civil war when Houthi forces entered the capital of Sanaa and forced Hadi to negotiate a "unity government" with other political factions. The Houthis continued their advance and influence over government operations until, after forces aligned with the Houthis reportedly attacked his presidential palace and private residence, Hadi resigned along with his ministers in January 2015. The following month, the Houthis declared themselves in control of the Yemeni government, dissolving the Parliament, and installing an interim Revolutionary Committee led by Mohammed al-Houthi, a cousin of Houthi leader Abdul-Malik al-Houthi. Hadi escaped to Aden, where he declared that he remained Yemen's legitimate president, proclaimed the country's temporary capital, and called on loyal government officials and members of the military to rally to him. Beginning in 2017 the separatist Southern Transitional Council (STC) began fighting against the government.
=== Gastric bypass surgery === Gastric bypass surgery not only reduces gut capacity for food, but also lowers ghrelin levels compared to both lean people and those who lost weight through dieting. Studies have not clarified whether ghrelin levels return to normal in people who had gastric bypass surgery after weight loss has stabilized. Gastric bypass surgery involving vertical-sleeve gastrectomy reduces plasma ghrelin levels by about 60% in the long term.
== Repackaging process and stability data == The transient or definitive displacement of the solid oral form from the original atmosphere to enter a repackaging process, sometimes automated, is likely to play a primary role in the pharmaceutical controversy in some countries. However, the solid oral dose is to be repackaged in materials with defined quality. Considering these data, a review of the literature for determination of conditions for repackaged drug stability according to different international guidelines is presented by F Lagrange.
== S == SAD – Selected area diffraction SAED – Selected area electron diffraction SAM – Scanning Auger microscopy SANS – Small angle neutron scattering SAXS – Small angle X-ray scattering SCANIIR – Surface composition by analysis of neutral species and ion-impact radiation SCEM – Scanning confocal electron microscopy SE – Spectroscopic ellipsometry SEC – Size exclusion chromatography SEIRA – Surface enhanced infrared absorption spectroscopy SEM – Scanning electron microscopy SERS – Surface enhanced Raman spectroscopy SERRS – Surface enhanced resonance Raman spectroscopy SESANS – Spin Echo Small Angle Neutron Scattering SEXAFS – Surface extended X-ray absorption fine structure SICM – Scanning ion-conductance microscopy SIL – Solid immersion lens SIM – Solid immersion mirror SIMS – Secondary ion mass spectrometry SNMS – Sputtered neutral species mass spectrometry SNOM – Scanning near-field optical microscopy SPECT – Single-photon emission computed tomography SPM – Scanning probe microscopy SRM-CE/MS – Selected-reaction-monitoring capillary-electrophoresis mass-spectrometry SSNMR – Solid-state nuclear magnetic resonance Stark spectroscopy STED – Stimulated emission depletion microscopy STEM – Scanning transmission electron microscopy STM – Scanning tunneling microscopy STS – Scanning tunneling spectroscopy SXRD – Surface X-ray diffraction
Sources: en.wikipedia.org
The World Health Organization in 1987 found that comfortable indoor temperatures of 18–24 °C (64–75 °F) were not associated with health risks for healthy adults with appropriate clothing, humidity, and other factors. For infants, elderly, and those with significant health problems, a minimum of 20 °C (68 °F) was recommended. Temperatures lower than 16 °C (61 °F) with humidity above 65% were associated with respiratory hazards including allergies. The WHO's 2018 guidelines give a strong recommendation that a minimum of 18 °C (64 °F) is a "safe and well-balanced indoor temperature to protect the health of general populations during cold seasons". A higher minimum temperature may be necessary for vulnerable groups including children, the elderly, and people with cardiorespiratory disease and other chronic illnesses. However, the recommendation regarding risk of exposure to high indoor temperatures is only "conditional". Minimal-risk high temperatures range from about 21 to 30 °C (70 to 86 °F) depending on the region, with maximum acceptable temperatures between 25 and 32 °C (77 and 90 °F).
== Characteristics == Aerated chocolate is a foam, meaning it contains gas, which conventional chocolate lacks. This distinction gives aerated chocolate different physical properties and eating experiences than regular chocolate: they have a lower density, occupying more space for the same weight, are more brittle, and have a larger surface area. Chocolates held together by solid particles rather than fats have the lowest density among aerated chocolates, between 0.1–0.3 g/cm3 (0.058–0.17 oz/cu in), several times lower than the average density of regular chocolate (around 1.3 g/cm3 (0.75 oz/cu in)). As a result of these properties, biting into some aerated chocolates, particularly those with larger bubbles, produces an audible crunch. When the chocolate enters the mouth, a "fragile" mouthfeel is created until the chocolate is chewed, upon which it quickly begins to melt and the mouthfeel shifts to become creamy. The way the chocolate melts changes with the size of bubbles: as they get smaller, the chocolate becomes smoother and melts quicker. In the fourth type of aerated chocolate, those held together by solid particle skeletons rather than with fat, the chocolate doesn't melt with heat as conventional chocolate does. Rather, because of its very low density, as it enters the mouth it dissolves. Aerated chocolates have a more intense flavour than conventional chocolates due to their larger surface area. The gas used to aerate chocolates also has an effect on the intensity of flavour, although a comparatively small one.
== Chemistry of experiment == In 1957 Miller published research describing the chemical processes occurring inside his experiment. Hydrogen cyanide (HCN) and aldehydes (e.g., formaldehyde) were demonstrated to form as intermediates early on in the experiment due to the electric discharge. This agrees with current understanding of atmospheric chemistry, as HCN can generally be produced from reactive radical species in the atmosphere that arise when CH4 and nitrogen break apart under ultraviolet (UV) light. Similarly, aldehydes can be generated in the atmosphere from radicals resulting from CH4 and H2O decomposition and other intermediates like methanol. Several energy sources in planetary atmospheres can induce these dissociation reactions and subsequent hydrogen cyanide or aldehyde formation, including lightning, ultraviolet light, and galactic cosmic rays. For example, here is a set photochemical reactions of species in the Miller–Urey atmosphere that can result in formaldehyde:
=== Neurotransmitters === T3 may increase serotonin in the brain, in particular in the cerebral cortex, and down-regulate 5HT-2 receptors, based on studies in which T3 reversed learned helplessness in rats and physiological studies of the rat brain.
=== Mechanical engineering === When a periodic force is applied to a mechanical system, it will typically reach a steady state after going through some transient behavior. This is often observed in vibrating systems, such as a clock pendulum, but can happen with any type of stable or semi-stable dynamic system. The length of the transient state will depend on the initial conditions of the system. Given certain initial conditions, a system may be in steady state from the beginning.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.